DOSSIER · 13F-HR · Q3 2026

GENERAL ATLANTIC, L.P.

$2.5B in tracked AUM across 12 positions as of Q3 2026.

GA
CIK 0001017645 · last filed Sep 30, 2026
Total AUM
$2.5B
as of Q3 2026
Holdings
12
+0 QoQ
positions
Whale Score
83
83
strong
Activity
7
+1 new, −1 sold
changes this Q
AI Analysis · Q3 2026

GENERAL ATLANTIC, L.P. filed its latest 13F-HR for Q3 2026. 7 position changes this quarter — 1 new, 1 exited, 1 added, 4 trimmed.

Quarter at a glance — Q3 2026

7 material changes this filing.

TRIM
N69605108PHARVARIS
-4.9M sh
$-174M
2.1%
TRIM
G29018101DLOCAL
-9.8M sh
$-100M
20.4%
TRIM
CHYMCHIME
-2.3M sh
+$69M
20.3%
EXIT
RVMDREVOLUTION MEDICINES
-358K sh
$-67M
—
ADD
M8216R109RISKIFIED
+5.3M sh
+$57M
3.4%
NEW
KRSAKORSANA
+1.4M sh
+$44M
1.8%
TRIM
G98239109XP, INC
-2.6M sh
+$43M
15.2%

Top 10 holdings

By portfolio weight as of Q3 2026. Source: SEC EDGAR 13F-HR filings.

#HoldingValueSharesWeight
01
G29018101
DLOCAL
$507M36.8M20.4%
02
CHYM
CHIME
$504M18.9M20.3%
03
LFTO
LIFTOFF MOBILE
$400M25.3M16.1%
04
G98239109
XP, INC
$377M18.0M15.2%
05
ALKT
ALKAMI
$265M19.4M10.7%
06
SPTX
SEAPORT THERAPEUTICS
$123M6.1M5.0%
07
M8216R109
RISKIFIED
$84M10.6M3.4%
08
NRIX
NURIX THERAPEUTICS
$72M3.0M2.9%
09
N69605108
PHARVARIS
$52M1.7M2.1%
10
PBLS
PARABILIS MEDICINES
$50M1.5M2.0%

Filing history

2026Q3Sep 30
$2.5B▼ 14.7%
12 positionsView →
2026Q2Jun 30
$2.9B▲ 35.3%
12 positionsView →
2026Q1Mar 31
$2.1B▼ 25.2%
12 positionsView →
2025Q4Dec 31
$2.9B▼ 6.8%
13 positionsView →
2025Q3Sep 30
$3.1B▼ 15.0%
13 positionsLocked
2025Q2Jun 30
$3.6B▲ 28.1%
15 positionsLocked
2025Q1Mar 31
$2.8B▲ 0.9%
13 positionsLocked
2024Q4Dec 31
$2.8B▼ 20.1%
16 positionsLocked
2024Q3Sep 30
$3.5B▲ 10.6%
18 positionsLocked
2024Q2Jun 30
$3.2B▼ 26.1%
19 positionsLocked
2024Q1Mar 31
$4.3B▼ 38.2%
22 positionsLocked
2023Q4Dec 31
$7.0B▲ 7.6%
26 positionsLocked
Showing 12 of 72